SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-079142
Filing Date
2022-12-12
Accepted
2022-12-12 17:04:12
Documents
13
Period of Report
2022-12-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea169921-8k_inmunebio.htm   iXBRL 8-K 28698
2 AMENDMENT NO. 2 TO RIGHTS AGREEMENT, DATED AS OF DECEMBER 9, 2022, BETWEEN THE C ea169921ex4-1_inmunebio.htm EX-4.1 15664
  Complete submission text file 0001213900-22-079142.txt   223358

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE inmb-20221209.xsd EX-101.SCH 3230
4 XBRL LABEL FILE inmb-20221209_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE inmb-20221209_pre.xml EX-101.PRE 22361
7 EXTRACTED XBRL INSTANCE DOCUMENT ea169921-8k_inmunebio_htm.xml XML 3714
Mailing Address 225 NE MIZNER BLVD, SUITE 640 BOCA RATON FL 33432
Business Address 225 NE MIZNER BLVD, SUITE 640 BOCA RATON FL 33432 8589643720
Inmune Bio, Inc. (Filer) CIK: 0001711754 (see all company filings)

IRS No.: 475205835 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38793 | Film No.: 221457807
SIC: 2836 Biological Products, (No Diagnostic Substances)